|
May 1
|
Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 30
|
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
|
|
Apr 25
|
Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance
|
|
Apr 22
|
Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support
|
|
Apr 16
|
Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News
|
|
Apr 15
|
Ironwood Shares Tank on Regulatory Update for Apraglutide
|
|
Apr 15
|
Ironwood’s shares sink as FDA demands new trial for lead drug
|
|
Apr 14
|
Sector Update: Health Care Stocks Rise Late Afternoon
|
|
Apr 14
|
Top Midday Decliners
|
|
Apr 14
|
Sector Update: Health Care Stocks Rise Monday Afternoon
|
|
Apr 14
|
Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide
|
|
Aug 29
|
Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
|
|
Jul 25
|
Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call
|
|
Jun 12
|
Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD)
|
|
Feb 17
|
Ironwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
|
|
Feb 16
|
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript
|
|
Feb 16
|
Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
|
|
Feb 16
|
Q4 2023 Ironwood Pharmaceuticals Inc Earnings Call
|
|
Feb 15
|
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4
|
|
Feb 15
|
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
|